Literature review of rheumatoid arthritis in India

International Journal of Rheumatic Diseases

Volumn 19, Issue 5, 2016, Pages 440-451

  Handa, Rohini ^a   Rao, U R K ^b   Lewis, Juliana F M ^d   Rambhad, Gautam ^c   Shiff, Susan ^c   Ghia, Canna J ^c  

^a INDRAPRASTHA APOLLO HOSPITAL   (India)

^b Sri Deepti Rheumatology Centre   (India)

^c PFIZER INC   (United States)

^d EVIDERA   (United States)

Author keywords

India; Literature review; Rheumatoid arthritis

Indexed keywords

AZATHIOPRINE; CHLOROQUINE; CORTICOSTEROID; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; CYCLOPHOSPHAMIDE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; GOLD; IMMUNOGLOBULIN; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLAMINE; RHEUMATOID FACTOR; SALAZOSULFAPYRIDINE; ANTIRHEUMATIC AGENT;

ARTICLE; COMORBIDITY; FUNCTIONAL STATUS; GEOGRAPHIC DISTRIBUTION; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; INCIDENCE; INDIAN; JUVENILE RHEUMATOID ARTHRITIS; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; QUALITY OF LIFE ASSESSMENT; RHEUMATOID ARTHRITIS; SHORT FORM 36; WORLD HEALTH ORGANIZATION QUALITY OF LIFE BREF TOOL; ARTHRITIS, RHEUMATOID; DISABILITY; INDIA; OBSERVATIONAL STUDY; RISK FACTOR; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; COMORBIDITY; DISABILITY EVALUATION; HUMANS; INDIA; OBSERVATIONAL STUDIES AS TOPIC; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84969988043     PISSN: 17561841     EISSN: 1756185X     Source Type: Journal    
DOI: 10.1111/1756-185X.12621     Document Type: Article

References (52)

1. Scott DL, Wolfe F, Huizinga TW (2010) Rheumatoid arthritis. Lancet 376 (9746), 1094-108.
2. Carmona L, Cross M, Williams B, Lassere M, March L (2010) Rheumatoid arthritis. Best Pract Res Clin Rheumatol 24, 733-45.
3. Avina-Zubieta JA, Choi HK, Sadatsafavi M, Etminan M, Esdaile JM, Lacaille D (2008) Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum 59, 1690-7.
4. Gonzalez A, Maradit Kremers H, Crowson CS et al. (2007) The widening mortality gap between rheumatoid arthritis patients and the general population. Arthritis Rheum 56, 3583-7.
5. Fatima F, Rao U, Moots R, Goodson N (2009) Raised traditional cardiovascular risk factors in Indians with rheumatoid arthritis. Arthritis Rheum 60 (S10), 948.
6. Government of India (2011) 2011 Census. Government of India: Office of the Registrar General and Census Commissioner (Ministry of Home Affairs). Available from URL: http://censusindia.gov.in/default.aspx. Office of the Registrar General and Census Commissioner, New Delhi.
7. Chopra A, Patil J, Billempelly V, Relwani J, Tandle HS (2001) Prevalence of rheumatic diseases in a rural population in western India: a WHO-ILAR COPCORD Study. J Assoc Physicians India 49, 240-6.
8. Mahajan A, Jasrotia DS, Manhas AS, Jamwal SS (2003) Prevalence of major rheumatic disorders in Jammu. JK Sci 5 (2), 63-6.
9. Joshi VL, Chopra A (2009) Is there an urban-rural divide? Population surveys of rheumatic musculoskeletal disorders in the Pune region of India using the COPCORD Bhigwan model. J Rheumatol 36, 614-22.
10. Malaviya AN, Kapoor SK, Singh RR, Kumar A, Pande I (1993) Prevalence of rheumatoid arthritis in the adult Indian population. Rheumatol Int 13 (4), 131-4.
11. Kar N (1994) A short communication on occurrence of rheumatic diseases attending hospital. Indian J Public Health 38 (3), 115-8.
12. Mathew AJ, Goyal V, George E et al. (2011) Rheumatic-musculoskeletal pain and disorders in a naive group of individuals 15 months following a Chikungunya viral epidemic in south India: a population based observational study. Int J Clin Pract 65, 1306-12.
13. Bhatt AD, Sane SP, Vaidya AB, Bolar HV (1993) Patterns of rheumatic diseases and antirheumatic drug usage in 11 931 Indian patients. J Assoc Physicians India 41 (9), 571-2.
14. Chopra A, Raghunath D, Singh A, Subramanian AR (1988) The pattern of rheumatoid arthritis in the Indian population: a prospective study. Br J Rheumatol 27, 454-6.
15. Aggarwal A, Agarwal V, Danda D, Misra R (2004) Outcome in juvenile rheumatoid arthritis in India. Indian Pediatr 41, 180-4.
16. Hadda V, Handa R, Aggarwal P, Lakshmy R, Kumar U, Pandey RM (2007) Diseases activity and lipids in rheumatoid arthritis: a prospective study. Indian J Rheumatol 2 (4), 137-40.
17. Bharadwaj A, Haroon N (2005) Interstitial lung disease and neuropathy as predominant extra-articular manifestations in patients with rheumatoid arthritis: a prospective study. Med Sci Monit 11 (10), CR498-502.
18. Haroon N, Aggarwal A, Lawrence A, Agarwal V, Misra R (2007) Impact of rheumatoid arthritis on quality of life. Mod Rheumatol 17, 290-5.
19. Mahajan V, Handa R, Kumar U et al. (2008) Assessment of atherosclerosis by carotid intimomedial thickness in patients with rheumatoid arthritis. J Assoc Physicians India 56, 587-90.
20. Irlapati RVP, Nagaprabu VN, Suresh K, Agrawal S, Gumdal N (2011) Infections in rheumatology practice: an experience from NIMS, Hyderabad. Indian J Rheumatol 6 (Suppl 1), 25-30.
21. Bedi GS, Gupta N, Handa R, Pal H, Pandey RM (2005) Quality of life in Indian patients with rheumatoid arthritis. Qual Life Res 14, 1953-8.
22. Shankar S, Handa R, Aneja R, Marwaha V, Ammini AC, Aprajita V (2009) Bone mineral density in Indian women with rheumatoid arthritis. Rheumatol Int 29, 377-81.
23. Aneja R, Singh MB, Shankar S et al. (2007) Prevalence of peripheral neuropathy in patients with newly diagnosed rheumatoid arthritis. Indian J Rheumatol 2 (2), 47-50.
24. Wakhlu A, Krisnani N, Hissaria P, Aggarwal A, Misra R (2003) Prevalence of secondary amyloidosis in Asian North Indian patients with rheumatoid arthritis. J Rheumatol 30, 948-51.
25. Grover S, Sinha RP, Singh U, Tewari S, Aggarwal A, Misra R (2006) Subclinical atherosclerosis in rheumatoid arthritis in India. J Rheumatol 33, 244-7.
26. Sudharshan S, Biswas J, Ganesh SK (2007) Analysis of juvenile idiopathic arthritis associated uveitis in India over the last 16 years. Indian J Ophthalmol 55 (3), 199-202.
27. Wakhlu A, Gupta D, Aggarwal A, Misra R (2003) Low levels of anti-histone antibodies in north Indian children with juvenile rheumatoid arthritis. Indian J Med Res 118, 204-7.
28. Dhir V, Lawrence A, Aggarwal A, Misra R (2009) Fibromyalgia is common and adversely affects pain and fatigue perception in North Indian patients with rheumatoid arthritis. J Rheumatol 36, 2443-8.
29. Agrawal S, Aggarwal A, Dabadghao S, Naik S, Misra R (1995) Compound heterozygosity of HLA-DR4 and DR1 antigens in Asian Indians increases the risk of extra-articular features in rheumatoid arthritis. Br J Rheumatol 34 (1), 41-4.
30. Aggarwal A, Chandran S, Misra R (2006) Physical, psychosocial and economic impact of rheumatoid arthritis: a pilot study of patients seen at a tertiary care referral centre. Natl Med J India 19 (4), 187-91.
31. Chogle AR, Mistry KJ, Deo SS (2008) Comparison of the Indian version of Health Assessment Questionnaire Score and Short Form 36 Physical Function Score in rheumatoid arthritis using Rasch analysis. Indian J Rheumatol 3 (2), 52-7.
32. Deo SS, Chogle AR, Mistry KJ, Shetty RR, Nadkar UL (2012) Increased prevalence of subclinical atherosclerosis in rheumatoid arthritis patients of Indian descent. Exp Clin Cardiol 17 (1), 20-5.
33. Bruce B, Fries J (2003) The Stanford Health Assessment Questionnaire: dimensions and practical applications. Health Qual Life Outcomes 1, 20.
34. Hawthorne G, Herrman H, Murphy B (2006) Interpreting the WHOQOL-Brèf: preliminary population norms and effect sizes. Soc Indic Res 77 (1), 37-59.
35. Escalante A, Haas RW, del Rincon I (2004) Measurement of global functional performance in patients with rheumatoid arthritis using rheumatology function tests. Arthritis Res Ther 6 (4), R315-25.
36. Agarwal S, Zaman T, Handa R (2009) Retention rates of disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis. Singapore Med J 50, 686-92.
37. Shankar S, Grover R, Handa R (2006) Role of anti cyclic citrullinated peptide antibodies in erosive disease in patients with rheumatoid arthritis. Indian J Med Res 124, 689-96.
38. Alamanos Y, Voulgari PV, Drosos AA (2006) Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review. Semin Arthritis Rheum 36 (3), 182-8.
39. Akhter E, Bilal S, Kiani A, Haque U (2011) Prevalence of arthritis in India and Pakistan: a review. Rheumatol Int 31, 849-55.
40. Gupta R, Thabah MM, Aneja R, Kumar A, Verghese T, Chandrasenan P (2009) Usefulness of anti-CCP antibodies in rheumatic diseases in Indian patients. Indian J Med Sci 63 (3), 92-100.
41. Misra R, Sharma BL, Gupta R et al. (2008) Indian Rheumatology Association consensus statement on the management of adults with rheumatoid arthritis. Indian J Rheumatol 3, S1-16.
42. Director General of Health Services, Ministry of Health and Family Welfare, Government of India. Central drugs standard control organization: list of new drugs approved for marketing in India. Available from URL: http://www.cdsco.nic.in/forms/list.aspx?lid=1820&Id=11.
43. Rao UR, Thopu AR, Naidu MU, Kumar T (1990) Early beneficial effects of low dose oral methotrexate in rheumatoid arthritis. J Assoc Physicians India 38 (5), 335-6.
44. Vardhan H, Kabra P, Rohatgi K, Singh RR, Malaviya A (1988) Sulphasalazine in the treatment of rheumatoid arthritis in India. J Assoc Physicians India 36 (5), 350.
45. Chandrasekaran AN, Radhakrishna B (1995) Rheumatoid arthritis and connective tissue disorders: India and South-East Asia. Baillieres Clin Rheumatol 9 (1), 45-57.
46. Malaviya A, Haroon N (2011) Infections associated with the use of biologic response modifiers in rheumatic diseases: a critical appraisal. Indian J Rheumatol 6 (1 Suppl), 99-112.
47. Kumar A (2006) Experience with anti-tumor necrosis factor-alpha therapy in India. APLAR J Rheumatol 9, 136-41.
48. Chaturvedi V, Singal V, Rai R (2002) Efficacy and toxicity of anti-TNF antibody in polyarticular juvenile arthritis. Arthritis Rheum 4 (Abstract).
49. Narayanan K, Shanmuganandan K (2003) Safety and efficacy profile of infliximab in inflammatory arthritis. J Indian Rheumatol Assoc 11(1) (Abstract).
50. Misra R, Amin S, Joshi VR et al. (2005) Open-label evaluation of the efficacy and safety of etanercept in rheumatoid arthritis. J Indian Rheumatol Assoc 13, 131-4.
51. Hoebert JM, Mantel-Teeuwisse AK, van Dijk L, Bijlsma JW, Leufkens HG (2012) Do rheumatoid arthritis patients have equal access to treatment with new medicines? Tumour necrosis factor-alpha inhibitors use in four European countries. Health Policy 104 (1), 76-83.
52. Zaman T, Agarwal S, Handa R (2007) Complementary and alternative medicine use in rheumatoid arthritis: an audit of patients visiting a tertiary care centre. Natl Med J India 20 (5), 236-9.